» Articles » PMID: 31496908

Thiol/Disulphide Homeostasis, Ischemia Modified Albumin, and Ferroxidase As Oxidative Stress Markers in Women with Obesity with Insulin Resistance

Overview
Journal J Med Biochem
Specialty Biochemistry
Date 2019 Sep 10
PMID 31496908
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The purpose of the study was to determine oxidative stress-related plasma thiol/disulphide, ischemia-modified albumin (IMA) levels and ferroxidase activity among women with obesity in insulin-resistant and non-insulin-resistant groups in comparison with an overweight group.

Methods: We compared plasma thiol/disulphide, IMA levels, and ferroxidase activity between the study groups. We analyzed plasma thiol/disulphide homeostasis with a newly developed automated measurement method; IMA with Albumin Cobalt Binding Test and ferroxidase (ceruloplasmin) levels with an automated, colourimetric method.

Results: There were no significant differences between insulin-resistant and non-insulin-resistant women with obesity in terms of plasma native thiol, total thiol, disulphide, disulphide/native thiol ratio, disulphide/total thiol or native thiol/total thiol values. Ferroxidase activity was higher in insulin-resistant than in non-insulin-resistant women with obesity and higher in the total women with obesity group than in the overweight subjects (p<0.001, and p=0.014, respectively). IMA was lower in the insulin-resistant group than in the non-insulin-resistant group and overweight groups (p=0.011, and p=0.042, respectively).

Conclusions: The significantly greater increase in ferroxidase activity in insulin-resistant subjects with obesity may reflect its role as a positive acute phase protein. These findings may be related to the pathogenesis of the disease. Changes in oxidative status occur in women with obesity, and partially in overweight subjects. The ferroxidase activity of ceruloplasmin plays a crucial role in iron homeostasis and lowers oxidative stress by reducing the detrimental effects of iron.

Citing Articles

A Prediction Model of the Incidence of Type 2 Diabetes in Individuals with Abdominal Obesity: Insights from the General Population.

Tan C, Li B, Xiao L, Zhang Y, Su Y, Ding N Diabetes Metab Syndr Obes. 2022; 15:3555-3564.

PMID: 36411787 PMC: 9675349. DOI: 10.2147/DMSO.S386687.


Study of the Association between Thiols and Oxidative Stress Markers in Children with Obesity.

DAlessandro A, Di Felice G, Manco M, Pastore A, Pezzi S, Mariani M Nutrients. 2022; 14(17).

PMID: 36079892 PMC: 9460844. DOI: 10.3390/nu14173637.


Evaluation of the Association between Obesity Markers and Type 2 Diabetes: A Cohort Study Based on a Physical Examination Population.

Yang T, Zhao B, Pei D J Diabetes Res. 2022; 2021:6503339.

PMID: 34993251 PMC: 8727144. DOI: 10.1155/2021/6503339.


Factorial Analysis of the Cardiometabolic Risk Influence on Redox Status Components in Adult Population.

Klisic A, Kavaric N, Vujcic S, Spasojevic-Kalimanovska V, Kotur-Stevuljevic J, Ninic A Oxid Med Cell Longev. 2021; 2021:6661940.

PMID: 33936384 PMC: 8062197. DOI: 10.1155/2021/6661940.


Serum endocan levels in relation to traditional and non-traditional anthropometric indices in adult population.

Klisic A, Kavaric N, Spasojevic-Kalimanovska V, Kotur-Stevuljevic J, Ninic A J Med Biochem. 2021; 40(1):41-48.

PMID: 33584139 PMC: 7857850. DOI: 10.5937/jomb0-25170.


References
1.
Bar-Or D, Lau E, Winkler J . A novel assay for cobalt-albumin binding and its potential as a marker for myocardial ischemia-a preliminary report. J Emerg Med. 2000; 19(4):311-5. DOI: 10.1016/s0736-4679(00)00255-9. View

2.
Takeuchi Y, Yoshikawa M, Tsujino T, Kohno S, Tsukamoto N, Shiroi A . A case of aceruloplasminaemia: abnormal serum ceruloplasmin protein without ferroxidase activity. J Neurol Neurosurg Psychiatry. 2002; 72(4):543-5. PMC: 1737827. DOI: 10.1136/jnnp.72.4.543. View

3.
Dandona P, Aljada A, Bandyopadhyay A . Inflammation: the link between insulin resistance, obesity and diabetes. Trends Immunol. 2003; 25(1):4-7. DOI: 10.1016/j.it.2003.10.013. View

4.
Hildebrandt W, Hamann A, Krakowski-Roosen H, Kinscherf R, Dugi K, Sauer R . Effect of thiol antioxidant on body fat and insulin reactivity. J Mol Med (Berl). 2004; 82(5):336-44. DOI: 10.1007/s00109-004-0532-5. View

5.
Healy J, Tipton K . Ceruloplasmin and what it might do. J Neural Transm (Vienna). 2007; 114(6):777-81. DOI: 10.1007/s00702-007-0687-7. View